BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 19818304)

  • 1. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ; Chitturi S; Heydet D; Farrell GC
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From a glucocentric to a lipocentric approach towards metabolic syndrome.
    Mittra S; Bansal VS; Bhatnagar PK
    Drug Discov Today; 2008 Mar; 13(5-6):211-8. PubMed ID: 18342796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP; Teodoro JS; Palmeira CM
    Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J; Choi SS; Diehl AM
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Roden M
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids and insulin resistance.
    Delarue J; Magnan C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.